The Manual Resuscitator Market size was valued at USD 640.4 million in 2024 and is anticipated to reach USD 1,036.2 million by 2032, growing at a CAGR of 6.2% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Manual Resuscitator Market Size 2024
USD 640.4 million
Manual Resuscitator Market, CAGR
6.2%
Manual Resuscitator Market Size 2032
USD 1,036.2 million
Manual Resuscitator Market Insights
Rising adoption in emergency and pre-hospital care, increasing awareness of infection control, and technological advancements such as smart monitoring and ergonomic designs are key drivers supporting market growth.
Integration of smart monitoring features, real-time feedback systems, and expansion of homecare applications, especially in Asia-Pacific, Latin America, and the Middle East, are significant market trends creating new growth opportunities.
High cost of advanced and premium devices, regulatory compliance, and product standardization challenges restrain market growth, particularly in emerging and price-sensitive regions.
North America leads with 32.4% share in 2024, Europe holds 28.1%, Asia-Pacific 22.7%, Latin America 9.6%, and the Middle East & Africa 7.2%, reflecting strong regional adoption and market potential.
Manual Resuscitator Market Segmentation Analysis:
By Type
The Manual Resuscitator market is segmented into Self-inflating, Flow-inflating, and T-piece devices. Among these, Self-inflating resuscitators dominate the market, accounting for 61.5% share in 2024, driven by their ease of use in emergency settings, portability, and compatibility with various patient populations, including neonates, pediatrics, and adults. Growing adoption in pre-hospital and in-hospital emergency care, coupled with increased awareness among first responders and healthcare professionals, further fuels demand. The versatility and requirement for rapid ventilation support remain key drivers for this sub-segment’s market leadership.
For instance, Laerdal’s Silicone Resuscitator (LSR) provides transparent silicone material for excellent bag re-expansion, resistant to extreme temperatures, and superior feel of lung compliance to reduce over-inflation risk.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
The market is classified into Disposable and Reusable manual resuscitators. Disposable resuscitators hold the largest share at 57.8% in 2024, primarily due to heightened concerns over cross-contamination and hospital-acquired infections. Rising regulatory emphasis on single-use medical devices, combined with the need for infection control in critical care units, drives adoption. These devices also offer operational convenience by eliminating the need for sterilization and maintenance, making them highly preferred in emergency care, ambulatory services, and outpatient settings across global healthcare facilities.
For instance, Teleflex’s Hudson RCI Lifesaver disposable manual resuscitator features a 40cm pressure relief valve and Star-Lumen oxygen tubing to prevent overinflation and ensure consistent airflow, minimizing cross-contamination in code blue events, patient transport, and field rescues.
By Material
The market includes Silicon, PVC, and Rubber manual resuscitators. Silicon-based resuscitators are the dominant sub-segment with a 52.6% share in 2024, owing to their durability, flexibility, and resistance to high-temperature sterilization processes. The biocompatibility and chemical stability of silicon make it suitable for repeated use in critical and neonatal care. Increasing investments in premium healthcare devices and growing preference for long-lasting, reliable materials in hospitals and emergency care centers further support market growth. Silicon’s superior performance and user safety remain primary drivers for this segment’s leading position.
Key Growth Drivers
Rising Adoption in Emergency and Pre-Hospital Care
The growing emphasis on rapid intervention in critical and pre-hospital settings is a primary growth driver for the Manual Resuscitator market. Healthcare providers increasingly rely on these devices for immediate ventilation support during emergencies, ambulatory care, and disaster response. The ease of portability, compatibility with different patient populations including neonates and adults, and ability to function without a power source make manual resuscitators indispensable. Government initiatives promoting emergency preparedness and first responder training further enhance demand. Hospitals, clinics, and emergency medical services are investing in high-quality resuscitators, driving significant market expansion across developed and emerging regions.
For instance, Ambu resuscitators feature on standardized ambulance equipment lists from the American College of Surgeons Committee on Trauma and other emergency organizations. These devices support hospital crash carts and bedsides for rapid ventilation.
Rising Awareness of Infection Control and Disposable Devices
Increasing concerns over hospital-acquired infections and cross-contamination are boosting demand for disposable manual resuscitators. Hospitals and critical care centers prioritize single-use devices to maintain stringent hygiene standards, particularly in neonatal, pediatric, and intensive care units. Regulatory bodies worldwide are advocating for disposable medical equipment to ensure patient safety, encouraging healthcare facilities to replace reusable devices with disposable alternatives. The operational convenience of eliminating sterilization requirements, coupled with faster availability during emergencies, supports adoption. These factors collectively position disposable resuscitators as a preferred solution, fueling market growth and driving innovation in infection-control-focused product designs.
For instance, GaleMed’s Dispo-Bag manual resuscitator, available in adult, pediatric, and infant sizes, reduces cross-contamination in ICUs and emergency rooms as a latex-free, single-use device meeting strict infection control protocols.
Technological Advancements and Material Innovation
Technological improvements and material innovations significantly contribute to market growth. Advanced materials such as high-grade silicon offer enhanced durability, flexibility, and resistance to repeated sterilization, appealing to both reusable and premium device segments. Ergonomic designs, integrated safety valves, and improved flow control mechanisms enhance ease of use and patient safety. Manufacturers are also developing lightweight, portable models that cater to field applications and neonatal care. These innovations improve device efficiency, reliability, and adoption across hospitals, emergency services, and homecare settings. Continuous R&D investment supports differentiation, increases clinical confidence, and expands the overall market footprint globally.
Key Trends & Opportunities
Integration with Smart Monitoring and Patient Safety Features
The integration of smart monitoring features, such as pressure sensors and real-time feedback systems, represents a significant trend and opportunity in the Manual Resuscitator market. These technologies allow healthcare professionals to monitor ventilation parameters accurately, reducing the risk of hypoxia or barotrauma. Coupled with ergonomic and lightweight designs, smart resuscitators are gaining traction in neonatal, pediatric, and adult care. Increasing adoption of digital health solutions in hospitals and pre-hospital emergency services creates opportunities for premium device segments. Manufacturers can capitalize on this trend by developing connected, intelligent resuscitators that enhance patient safety and operational efficiency, strengthening their market positioning.
For instance, Laerdal’s Upright Resuscitator for newborns integrates a pressure-limiting valve set at 30-45 cm H₂O alongside an optional PEEP valve delivering approximately 6 cm H₂O.
Expansion in Emerging Markets and Homecare Applications
Emerging markets present substantial growth opportunities due to increasing healthcare infrastructure investments and rising awareness of respiratory care. Countries in Asia-Pacific, Latin America, and the Middle East are witnessing higher demand for manual resuscitators in hospitals, ambulatory services, and homecare settings. Homecare adoption is being driven by rising chronic respiratory illnesses and aging populations requiring patient-managed ventilation support. Manufacturers targeting these markets can leverage cost-effective, portable, and disposable resuscitators to expand their footprint. Strategic collaborations, government support, and distribution network expansion in these regions provide a strong growth avenue for market players while addressing unmet healthcare needs.
For instance, in South Korea, INSUNG Medical and JW Medical are enhancing manual resuscitator performance through design innovations that improve portability and control, supported by government programs for medical device modernization.
Key Challenges
High Cost of Advanced and Premium Devices
The high cost of technologically advanced manual resuscitators, particularly models with smart monitoring systems or premium silicon materials, poses a challenge for widespread adoption. Smaller hospitals, clinics, and emerging market healthcare facilities may find such devices financially prohibitive. This cost barrier restricts market penetration in price-sensitive regions and limits accessibility for low-resource emergency and pre-hospital care units. Additionally, the initial investment in training healthcare professionals to use advanced devices effectively can add to operational expenses. Balancing innovation with affordability remains a critical challenge for manufacturers seeking broader adoption and sustained growth.
Regulatory Compliance and Product Standardization
Stringent regulatory requirements for medical devices, including manual resuscitators, present a significant challenge for market players. Compliance with international standards for safety, efficacy, sterilization, and biocompatibility can increase product development timelines and costs. Varying regulatory frameworks across countries complicate global market entry, creating hurdles for manufacturers. Ensuring standardization in performance, material quality, and design is crucial to gain regulatory approvals and clinical trust. Delays or non-compliance may lead to product recalls, litigation risks, or market restrictions, making regulatory alignment a persistent challenge for growth in this highly regulated healthcare segment.
Regional Analysis
North America
The North American Manual Resuscitator market holds a 32.4% share in 2024, driven by well-established healthcare infrastructure, high prevalence of chronic respiratory disorders, and increasing emergency care initiatives. Widespread adoption of technologically advanced devices, including smart monitoring and disposable resuscitators, supports market growth. Government programs promoting first responder training and pre-hospital emergency preparedness further boost demand. Presence of key players such as Philips Healthcare, Medline Industries, and GE Healthcare enhances product availability and distribution efficiency. Increasing investment in hospital emergency units and homecare respiratory support solutions continues to propel market expansion across the United States and Canada.
Europe
Europe accounts for 28.1% share in 2024 of the Manual Resuscitator market, supported by robust healthcare systems, regulatory compliance standards, and high awareness of patient safety. Adoption of disposable and silicon-based resuscitators is accelerating, particularly in neonatal and intensive care units. Countries such as Germany, France, and the UK are investing in emergency preparedness and advanced hospital equipment. The presence of established manufacturers including Dräger Medical AG & Co., Ambu A/S, and Weinmann Emergency ensures high product penetration. Rising demand for portable and reusable resuscitators in pre-hospital and ambulatory care settings continues to drive regional growth.
Asia-Pacific
Asia-Pacific represents 22.7% share in 2024 of the Manual Resuscitator market, propelled by increasing healthcare infrastructure investments, expanding emergency medical services, and rising awareness of respiratory care. Growing neonatal and adult patient populations, coupled with rising incidences of chronic respiratory diseases, fuel demand for both disposable and reusable devices. Countries such as China, India, and Japan are witnessing high adoption of cost-effective, portable resuscitators. Collaborations between global manufacturers and regional distributors are enhancing product accessibility. Additionally, government initiatives to improve emergency response and rural healthcare capabilities provide significant opportunities for market expansion across the region.
Latin America
Latin America holds a 9.6% share in 2024 of the Manual Resuscitator market, driven by increasing investments in hospital infrastructure, emergency care training programs, and rising prevalence of respiratory illnesses. Countries such as Brazil and Mexico are adopting disposable and self-inflating resuscitators to improve patient safety and reduce infection risks. The expanding private healthcare sector and growing focus on pre-hospital emergency services are fueling demand. Collaborations with local distributors by global manufacturers such as Laerdal Medical and Ambu A/S enhance market reach. However, price sensitivity in the region encourages adoption of cost-effective, durable resuscitators suitable for widespread use.
Middle East & Africa
The Middle East & Africa region accounts for 7.2% share in 2024 of the Manual Resuscitator market, supported by growing healthcare infrastructure investments and increasing awareness of emergency medical care. Countries including Saudi Arabia, UAE, and South Africa are expanding hospital and pre-hospital emergency facilities. Rising demand for portable, disposable, and silicon-based resuscitators, particularly for neonatal and adult care, drives growth. Strategic partnerships between regional distributors and global manufacturers such as ResMed, Inc., and CareFusion (BD) enhance product availability. Government initiatives to improve emergency response capabilities and training programs for first responders further contribute to market expansion across the region.
Manual Resuscitator Market Segmentations:
By Type :
Self-inflating
Flow-inflating
T-piece
By Modality :
Disposable
Reusable
By Material :
Silicon
PVC
Rubber
By Application :
Chronic Obstructive Pulmonary Disease
Cardiopulmonary Arrest
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
South-east Asia
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of the Middle East and Africa
Competitive Landscape
Competitive landscape of the Manual Resuscitator Market features key players including Ambu A/S, Laerdal Medical, Philips Healthcare, Covidien (Medtronic), Dräger Medical AG & Co., GE Healthcare, Medline Industries, ResMed, Inc., Weinmann Emergency, and CareFusion (BD). These companies dominate the market through a combination of innovative product portfolios, technological advancements, and expansive distribution networks. They focus on introducing disposable, reusable, and silicon-based resuscitators tailored to neonatal, pediatric, and adult care, enhancing patient safety and usability. Strategic partnerships, acquisitions, and regional expansions strengthen their market presence globally. Investment in R&D for ergonomic designs, smart monitoring, and portable solutions drives differentiation. Emphasis on regulatory compliance, quality certifications, and rapid response to emergency care demands ensures sustained adoption of their products. Competitive pricing and collaboration with hospitals, emergency services, and distributors allow these players to maintain leadership while capturing growth opportunities across North America, Europe, and emerging markets.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
In August 2025, Ambu Inc. issued a recall of certain SPUR II manual resuscitators due to a blocked manometer port that rendered the pressure monitoring feature non‑functional, prompting an Urgent Field Safety Notice to healthcare providers to remove affected units from use.
In May 2025, Laerdal Medical launched a compact, single-use manual resuscitator tailored for ambulances and emergency transport, emphasizing lightweight design and lower cross-contamination risks.
Report Coverage
The research report offers an in-depth analysis based on Type,Modality, Material, Applicationand Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
The demand for portable and lightweight manual resuscitators will continue to rise across pre-hospital and emergency care settings.
Adoption of disposable resuscitators will expand due to increased focus on infection control and hygiene standards.
Technological innovations, including smart monitoring and ergonomic designs, will drive premium segment growth.
Growth in neonatal and pediatric care will fuel demand for specialized resuscitator devices.
Emerging markets in Asia-Pacific, Latin America, and the Middle East will offer significant expansion opportunities.
Strategic collaborations and partnerships between manufacturers and regional distributors will enhance market reach.
Investment in training programs for first responders and healthcare professionals will boost adoption.
Increasing prevalence of chronic respiratory diseases will sustain long-term demand for manual resuscitators.
Manufacturers will focus on durable, silicon-based materials for reusable and high-performance devices.
Regulatory compliance and standardization will remain critical for product development and global market entry.
Introduction
1.1. Report Description
1.2. Purpose of the Report
1.3. USP & Key Offerings
1.4. Key Benefits for Stakeholders
1.5. Target Audience
1.6. Report Scope
1.7. Regional Scope
Scope and Methodology
2.1. Objectives of the Study
2.2. Stakeholders
2.3. Data Sources
2.3.1. Primary Sources
2.3.2. Secondary Sources
2.4. Market Estimation
2.4.1. Bottom-Up Approach
2.4.2. Top-Down Approach
2.5. Forecasting Methodology
Executive Summary
Introduction
4.1. Overview
4.2. Key Industry Trends
Global Manual Resuscitator Market
5.1. Market Overview
5.2. Market Performance
5.3. Impact of COVID-19
5.4. Market Forecast
Market Breakup by Region
10.1. North America
10.1.1. United States
10.1.2. Canada
10.2. Asia-Pacific
10.3. Europe
10.4. Latin America
10.5. Middle East and Africa
SWOT Analysis
Value Chain Analysis
Porter’s Five Forces Analysis
Price Analysis
Competitive Landscape
15.1. Market Structure
15.2. Key Players
15.3. Profiles of Key Players
15.3.1. Weinmann Emergency
15.3.2. GE Healthcare
15.3.3. ResMed, Inc.
15.3.4. Laerdal Medical
15.3.5. CareFusion (BD)
15.3.6. Medline Industries
15.3.7. Dräger Medical AG & Co.
15.3.8. Philips Healthcare
15.3.9. Ambu A/S
15.3.10. Covidien (Medtronic)
Research Methodology
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions:
What is the current market size for Manual Resuscitator Market, and what is its projected size in 2032?
The Manual Resuscitator Market size was valued at USD 640.4 million in 2024 and is projected to reach USD 1,036.2 million by 2032.
At what Compound Annual Growth Rate is the Manual Resuscitator Market projected to grow between 2024 and 2032?
The Manual Resuscitator Market is expected to grow at a CAGR of 6.2% during the forecast period.
Which Manual Resuscitator Market segment held the largest share in 2024?
By type, the Self-inflating segment dominated the Manual Resuscitator Market with 61.5% share in 2024.
What are the primary factors fueling the growth of the Manual Resuscitator Market?
Rising adoption in emergency and pre-hospital care, awareness of infection control, and technological advancements are key growth drivers for the Manual Resuscitator Market.
Who are the leading companies in the Manual Resuscitator Market?
Key players in the Manual Resuscitator Market include Ambu A/S, Laerdal Medical, Philips Healthcare, Covidien (Medtronic), Dräger Medical AG & Co., GE Healthcare, Medline Industries, ResMed, Inc., Weinmann Emergency, and CareFusion (BD).
Which region commanded the largest share of the Manual Resuscitator Market in 2024?
North America led the Manual Resuscitator Market with 32.4% share in 2024, driven by advanced healthcare infrastructure and emergency care adoption.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
The global bone growth stimulator market was valued at USD 1,890 million in 2024 and is projected to reach USD 3,058.14 million by 2032, expanding at a compound annual growth rate (CAGR) of 6.2% during the forecast period.
The global antioxidants market was valued at USD 4,095.8 million in 2024 and is anticipated to reach USD 6,657.29 million by 2032, expanding at a CAGR of 6.26% during the forecast period.
US Pharma R&D Outsourcing Market size was valued at USD 30,916.90 Million in 2024 and is anticipated to reach USD 67,782.11 Million by 2032, at a CAGR of 10.31% during the forecast period.
UAE Over-the-Counter (OTC) Pharmaceuticals Market size was valued at USD 2,913 million in 2024 and is anticipated to reach USD 4,110.63 million by 2032, at a CAGR of 4.4% during the forecast period.
The Prostatic Catheter Market size was valued at USD 199 million in 2024 and is anticipated to reach USD 309.44 million by 2032, at a CAGR of 5.7% during the forecast period.
The Rapid Microbiology Tests Market size was valued at USD 6,178 million in 2024 and is anticipated to reach USD 10496.15 million by 2032, at a CAGR of 6.85 % during the forecast period.
The Reversible Airway Diseases Treatment Market size was valued at USD 85,518 million in 2024 and is anticipated to reach USD 143671.9 million by 2032, at a CAGR of 6.7 % during the forecast period.
The RNA Targeting Small Molecule Drug Discovery Market size was valued at USD 1,723 million in 2024 and is anticipated to reach USD 8852.98 million by 2032, at a CAGR of 22.7 % during the forecast period.
The Rare Disease Clinical Trials Market size was valued at USD 12,949 million in 2024 and is anticipated to reach USD 21592.72 million by 2032, at a CAGR of 6.6 % during the forecast period.
The Rare Disease Genetic Testing Market size was valued at USD 1,197 million in 2024 and is anticipated to reach USD 3703.24 million by 2032, at a CAGR of 15.16 % during the forecast period.
The RAS Mutation Detection Kit Market size was valued at USD 107 million in 2024 and is anticipated to reach USD 188.53 million by 2032, at a CAGR of 7.4 % during the forecast period.
The Precision Medicine Market size was valued at USD 91,298 million in 2024 and is anticipated to reach USD 204409.6 million by 2032, at a CAGR of 10.6 % during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$3999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$4999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
